Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Stenman, UH' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 152 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Finne, P; Finne, R; Stenman, UH
      Neural network analysis of clinicopathological factors in urological disease: a critical evaluation of available techniques

      BJU INTERNATIONAL
    2. Prikk, K; Maisi, P; Sepper, R; Stenman, UH; Salo, T; Sorsa, T
      Association of trypsin-2 with activation of gelatinase B and collagenase-2in human bronchoalveolar lavage fluid in vivo

      ANNALS OF MEDICINE
    3. Louhimo, J; Nordling, S; Alfthan, H; von Boguslawski, K; Stenman, UH; Haglund, C
      Specific staining of human chorionic gonadotropin beta in benign and malignant gastrointestinal tissues with monoclonal antibodies

      HISTOPATHOLOGY
    4. Hakama, M; Aro, J; Auvinen, A; Juusela, H; Maattanen, L; Stenman, UH; Tammela, TLJ
      Randomized screening trial for prostate cancer in Finland

      EUROPEAN UROLOGY
    5. Finne, P; Auvinen, A; Stenman, UH
      Prostate cancer screening

      LANCET
    6. Stattin, P; Stenman, UH; Riboli, E; Hallmans, G; Kaaks, R
      Prostate cancer screening

      LANCET
    7. Sjostrom, J; Alfthan, H; Joensuu, H; Stenman, UH; Lundin, J; Blomqvist, C
      Serum tumour markers CA 15-3, TPA, TPS, hCG beta and TATI in the monitoring of chemotherapy response in metastatic breast cancer

      SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
    8. Hedstrom, J; Haglund, C; Leinonen, J; Nordling, S; Stenman, UH
      Trypsinogen-1,-2 and tumour-associated trypsin-inhibitor in bile and biliary tract tissues from patients with biliary tract diseases and pancreatic carcinomas

      SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
    9. Hakama, M; Stenman, UH; Aromaa, A; Leinonen, J; Hakulinen, T; Knekt, P
      Validity of the prostate specific antigen test for prostate cancer screening: Followup study with a bank of 21,000 sera in Finland

      JOURNAL OF UROLOGY
    10. Makinen, T; Tammela, TLJ; Hakama, M; Stenman, UH; Rannikko, S; Aro, J; Juusela, H; Maattanen, L; Auvinen, A
      Prostate cancer screening within a prostate specific antigen range of 3 to3.9 ng./ml.: A comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests

      JOURNAL OF UROLOGY
    11. Stenman, UH
      Serial prostate specific antigen, free-to-total prostate specific antigen ratio and complexed prostate specific antigen for the diagnosis of prostatecancer - Comment

      JOURNAL OF UROLOGY
    12. Isola, J; Auvinen, A; Poutiainen, M; Kakkola, L; Jarvinen, TAH; Maattanen, L; Stenman, UH; Tammela, T; Hakama, M; Visakorpi, T
      Predictors of biological aggressiveness of prostate specific antigen screening detected prostate cancer

      JOURNAL OF UROLOGY
    13. Paju, A; Jacobsen, J; Rasmuson, T; Stenman, UH; Ljungberg, B
      Tumor associated trypsin inhibitor as a prognostic factor in renal cell carcinoma

      JOURNAL OF UROLOGY
    14. Stattin, P; Soderberg, S; Hallmans, G; Bylund, A; Kaaks, R; Stenman, UH; Bergh, A; Olsson, T
      Leptin is associated with increased prostate cancer risk: A nested case-referent study

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    15. Vartiainen, J; Lehtovirta, P; Finne, P; Stenman, UH; Alfthan, H
      Preoperative serum concentration of hCG beta as a prognostic factor in ovarian cancer

      INTERNATIONAL JOURNAL OF CANCER
    16. Lundin, M; Nordling, S; Lundin, J; Alfthan, H; Stenman, UH; Haglund, C
      Tissue expression of human chorionic gonadotropin beta predicts outcome incolorectal cancer: A comparison with serum expression

      INTERNATIONAL JOURNAL OF CANCER
    17. Stattin, P; Rinaldi, S; Stenman, UH; Riboli, E; Hallmans, G; Bergh, A; Kaaks, R
      Plasma prolactin and prostate cancer risk: A prospective study

      INTERNATIONAL JOURNAL OF CANCER
    18. Stenman, UH
      Immunoassay standardization: Is it possible, who is responsible, who is capable?

      CLINICAL CHEMISTRY
    19. Andersen, JM; Hedstrom, J; Kemppainen, E; Finne, P; Puolakkainen, P; Stenman, UH
      The ratio of trypsin-2-alpha(1)-antitrypsin to trypsinogen-1 discriminatesbiliary and alcohol-induced acute pancreatitis

      CLINICAL CHEMISTRY
    20. Lempinen, M; Kylanpaa-Back, ML; Stenman, UH; Puolakkainen, P; Haapiainen, R; Finne, P; Korvuo, A; Kemppainen, E
      Predicting the severity of acute pancreatitis by rapid measurement of trypsinogen-2 in urine

      CLINICAL CHEMISTRY
    21. Turpeinen, U; Methuen, T; Alfthan, H; Laitinen, K; Salaspuro, M; Stenman, UH
      Comparison of HPLC and small column (CDTect) methods for disialotransferrin

      CLINICAL CHEMISTRY
    22. Paju, A; Sorsa, T; Tervahartiala, T; Koivunen, E; Haglund, C; Leminen, A; Wahlstrom, T; Salo, T; Stenman, UH
      The levels of trypsinogen isoenzymes in ovarian tumour cyst fluids are associated with promatrix metalloproteinase-9 but not promatrix metalloproteinase-2 activation

      BRITISH JOURNAL OF CANCER
    23. Hedstrom, J; Kemppainen, E; Andersen, J; Jokela, H; Puolakkainen, P; Stenman, UH
      A comparison of serum trypsinogen-2 and trypsin-2-alpha 1-antitrypsin complex with lipase and amylase in the diagnosis and assessment of severity in the early phase of acute pancreatitis

      AMERICAN JOURNAL OF GASTROENTEROLOGY
    24. Maattanen, L; Auvinen, A; Stenman, UH; Tammela, T; Rannikko, S; Aro, J; Juusela, H; Hakama, M
      Three-year results of the Finnish prostate cancer screening trial

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    25. Leinonen, J; Stenman, UH
      Reduced stability of prostate-specific antigen after long-term storage of serum at-20 degrees C

      TUMOR BIOLOGY
    26. Lundin, M; Nordling, S; Carpelan-Holmstrom, M; Louhimo, J; Alfthan, H; Stenman, UH; Haglund, C
      A comparison of serum and tissue hCG beta as prognostic markers in colorectal cancer

      ANTICANCER RESEARCH
    27. Stenman, UH; Finne, P; Zhang, WM; Leinonen, J
      Prostate-specific antigen and other prostate cancer markers

      UROLOGY
    28. Finne, P; Finne, R; Auvinen, A; Juusela, H; Aro, J; Maattanen, L; Hakama, M; Rannikko, S; Tammela, TLJ; Stenman, UH
      Predicting the outcome of prostate biopsy in screen-positive men by a multilayer perceptron network

      UROLOGY
    29. Zhang, WM; Finne, P; Leinonen, J; Salo, J; Stenman, UH
      Determination of prostate-specific antigen complexed to alpha(2)-macroclobulin in serum increases the specificity of free to total PSA for prostate cancer

      UROLOGY
    30. Kemppainen, E; Hietaranta, A; Puolakkainen, P; Hedstrom, J; Haapiainen, R; Stenman, UH
      Time course profile of serum trypsinogen-2 and trypsin-2-alpha(1)-antitrypsin in patients with acute pancreatitis

      SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
    31. Zhang, WM; Finne, P; Leinonen, J; Stenman, UH
      Characterization and determination of the complex between prostate-specific antigen and alpha(1)-protease inhibitor in benign and malignant prostaticdiseases

      SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
    32. Leinonen, J; Wu, P; Koivunen, E; Narvanen, A; Stenman, UH
      Development of novel peptide ligands modulating the enzyme activity of prostate-specific antigen

      SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
    33. Finne, P; Zhang, WM; Auvinen, A; Leinonen, J; Maattanen, L; Rannikko, S; Tammela, TLJ; Stenman, UH
      Use of the complex between prostate specific antigen and alpha 1-protease inhibitor for screening prostate cancer

      JOURNAL OF UROLOGY
    34. Finne, P; Auvinen, A; Koistinen, H; Zhang, WM; Maattanen, L; Rannikko, S; Tammela, T; Seppala, M; Hakama, M; Stenman, UH
      Insulin-like growth factor I is not a useful marker of prostate cancer in men with elevated levels of prostate-specific antigen

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    35. Lukkonen, A; Sorsa, T; Salo, T; Tervahartiala, T; Koivunen, E; Golub, L; Simon, S; Stenman, UH
      Down-regulation of trypsinogen-2 expression by chemically modified tetracyclines: Association with reduced cancer cell migration

      INTERNATIONAL JOURNAL OF CANCER
    36. Unkila-Kallio, L; Tiitinen, A; Alfthan, H; Vuorela, P; Stenman, UH; Ylikorkala, O
      Effect of an in vitro fertilization program on serum CA 125, tumor-associated trypsin inhibitor, free beta-subunit of human chorionic gonadotropin, and common alpha-subunit of glycoprotein hormones

      FERTILITY AND STERILITY
    37. Wu, P; Leinonen, J; Koivunen, E; Lankinen, H; Stenman, UH
      Identification of novel prostate-specific antigen-binding peptides modulating its enzyme activity

      EUROPEAN JOURNAL OF BIOCHEMISTRY
    38. Diamandis, EP; Yousef, GM; Clements, J; Ashworth, LK; Yoshida, S; Egelrud, T; Nelson, PS; Shiosaka, S; Little, S; Lilja, H; Stenman, UH; Rittenhouse, HG; Wain, H
      New nomenclature for the human tissue kallikrein gene family

      CLINICAL CHEMISTRY
    39. Kylanpaa-Back, ML; Kemppainen, E; Puolakkainen, P; Hedstrom, J; Haapiainen, R; Perhoniemi, V; Kivilaakso, E; Korvuo, A; Stenman, UH
      Reliable screening for acute pancreatitis with rapid urine trypsinogen-2 test strip

      BRITISH JOURNAL OF SURGERY
    40. Paju, A; Bjartell, A; Zhang, WM; Nordling, S; Borgstrom, A; Hansson, J; Stenman, UH
      Expression and characterization of trypsinogen produced in the human male genital tract

      AMERICAN JOURNAL OF PATHOLOGY
    41. Stattin, P; Bylund, A; Rinaldi, S; Biessy, C; Dechaud, H; Stenman, UH; Egevad, L; Riboli, E; Hallmans, G; Kaaks, R
      Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study

      JOURNAL OF THE NATIONAL CANCER INSTITUTE
    42. Laivuori, H; Kaaja, R; Turpeinen, U; Stenman, UH; Ylikorkala, O
      Serum activin A and inhibin A elevated in pre-eclampsia: no relation to insulin sensitivity

      BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY
    43. Stenman, J; Finne, P; Stahls, A; Grenman, R; Stenman, UH; Palotie, A; Orpana, A
      Accurate determination of relative messenger RNA levels by RT-PCR

      NATURE BIOTECHNOLOGY
    44. Stenman, UH; Leinonen, J; Zhang, WM; Finne, P
      Prostate-specific antigen

      SEMINARS IN CANCER BIOLOGY
    45. Lehtovirta, P; Alfthan, H; Vartiainen, J; Stenman, UH
      Skin metastases of gynecologic adenocarcinomas affect serum levels of hCG beta but not those of SCC antigen

      TUMOR BIOLOGY
    46. Stenman, UH; Paus, E; Allard, WJ; Andersson, I; Andres, C; Barnett, TR; Becker, C; Belenky, A; Bellanger, L; Pellegrino, CM; Bormer, OP; Davis, G; Dowell, B; Grauer, LS; Jette, DC; Karlsson, B; Kreutz, FT; van der Kwast, TM; Lauren, L; Leinimaa, M; Leinonen, J; Lilja, H; Linton, HJ; Nap, M; Nilsson, O; Ng, PC; Nustad, K; Peter, A; Pettersson, K; Piironen, T; Rapp, J; Rittenhouse, HG; Rye, PD; Seguin, P; Slota, J; Sokoloff, RL; Suresh, MR; Very, DL; Wang, TJ; Wigheden, I; Wolfert, RL; Yeung, KK; Zhang, WM; Zhou, Z; Hilgers, J
      Summary report of the TD-3 workshop: Characterization of 83 antibodies against prostate-specific antigen

      TUMOR BIOLOGY
    47. Leinonen, J; Zhang, WM; Paus, E; Stenman, UH
      Reactivity of 77 antibodies to prostate-specific antigen with isoenzymes and complexes of prostate-specific antigen

      TUMOR BIOLOGY
    48. Leinonen, J; Leinimaa, M; Zhang, WM; Piironen, T; Pettersson, K; Lilja, H; Dowell, B; Stenman, UH
      Reactivity of anti-PSA monoclonal antibodies with recombinant human kallikrein-2

      TUMOR BIOLOGY
    49. Alexander, FE; Andriole, GL; Aus, G; Auvinen, A; Beensterboer, P; Blijenberg, BG; Bonardi, R; Buys, S; Candas, B; Ciatto, S; Crawford, ED; Demers, R; de Koning, HJ; Denis, L; Dijk, MA; Figueiredo, F; Gellman, EP; Gohagan, J; Hakama, M; Hugosson, J; Kirkels, WI; Kranse, R; van der Kwast, TH; Lilja, H; Maattanen, L; Mandel, J; Miller, AB; Monteiro, H; Nelen, V; Oberman, A; Paez, A; Prorok, PC; Reding, D; Rietbergen, JWBW; Rose, DB; Sanchez, AB; Schroder, FH; da Silva, EC; Simpson, N; Smith, PH; Stadaert, B; Stenman, UH; Teppo, L; Turkes, A; Weissfeld, JL; Yokochi, L
      Rationale for randomised trials of prostate cancer screening

      EUROPEAN JOURNAL OF CANCER
    50. Vuorela-Vepsalainen, P; Alfthan, H; Orpana, A; Alitalo, K; Stenman, UH; Halmesmaki, E
      Vascular endothelial growth factor is bound in amniotic fluid and maternalserum

      HUMAN REPRODUCTION
    51. Stenman, UH
      Determination of alpha(1)-antichymotrypsin-PSA complex in serum does not improve the differentiation between benign prostatic hyperplasia and prostate cancer compared with total PSA and percent free PSA - Comment

      UROLOGY
    52. Stenman, UH
      Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomy - Editorial comment

      JOURNAL OF UROLOGY
    53. Valimaki, MJ; Tiitinen, A; Alfthan, H; Paetau, A; Poranen, A; Sane, T; Stenman, UH
      Ovarian hyperstimulation caused by gonadotroph adenoma secreting follicle-stimulating hormone 28-year-old woman

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    54. Hedstrom, J; Grenman, R; Ramsay, H; Finne, P; Lundin, J; Haglund, C; Alfthan, H; Stenman, UH
      Concentration of free hCG beta subunit in serum as a prognostic marker forsquamous-cell carcinoma of the oral cavity and oropharynx

      INTERNATIONAL JOURNAL OF CANCER
    55. Hotakainen, K; Lintula, S; Stenman, J; Rintala, E; Lindell, O; Stenman, UH
      Detection of messenger RNA for the beta-subunit of chorionic gonadotrophinin urinary cells from patients with transitional cell carcinoma of the bladder by reverse transcription-polymerase chain reaction

      INTERNATIONAL JOURNAL OF CANCER
    56. Lukkonen, A; Lintula, S; von Boguslawski, K; Carpen, O; Ljungberg, B; Landberg, G; Stenman, UH
      Tumor-associated trypsin inhibitor in normal and malignant renal tissue and in serum of renal-cell carcinoma patients

      INTERNATIONAL JOURNAL OF CANCER
    57. Virtanen, A; Gomari, M; Kranse, R; Stenman, UH
      Estimation of prostate cancer probability by logistic regression: Free andtotal prostate-specific antigen, digital rectal examination, and heredity are significant variables

      CLINICAL CHEMISTRY
    58. Stenman, UH
      New ultrasensitive assays facilitate studies on the role of human glandular kallikrein (hK2) as a marker for prostatic disease

      CLINICAL CHEMISTRY
    59. Zhang, WM; Finne, P; Leinonen, J; Vesalainen, S; Nordling, S; Stenman, UH
      Measurement of the complex between prostate-specific antigen and alpha(1)-protease inhibitor in serum

      CLINICAL CHEMISTRY
    60. Black, MH; Grass, CL; Leinonen, J; Stenman, UH; Diamandis, EP
      Characterization of monoclonal antibodies for prostate-specific antigen and development of highly sensitive free prostate-specific antigen assays

      CLINICAL CHEMISTRY
    61. Hedstrom, J; Haglund, C; Kemppainen, E; Leinimaa, M; Leinonen, J; Stenman, UH
      Time-resolved immunofluorometric assay of trypsin-I complexed with alpha(1)-antitrypsin in serum: Increased immunoreactivity in patients with biliarytract cancer

      CLINICAL CHEMISTRY
    62. Maattanen, L; Auvinen, A; Stenman, UH; Rannikko, S; Tammela, T; Aro, J; Juusela, H; Hakama, M
      European randomized study of prostate cancer screening: first-year resultsof the Finnish trial

      BRITISH JOURNAL OF CANCER
    63. VONKLEIST S; STENMAN UH
      PROSTATE-SPECIFIC ANTIGEN OR HUMAN KALLIKREIN-3 - RECENT DEVELOPMENTS- COMMENT

      Tumor biology
    64. KONTTINEN YT; HALINEN S; HANEMAAIJER R; SORSA T; HIETANEN J; CEPONIS A; XU JW; MANTHORPE R; WHITTINGTON J; LARSSON A; SALO T; KJELDSEN L; STENMAN UH; EISEN AZ
      MATRIX METALLOPROTEINASE (MMP)-9 TYPE-IV COLLAGENASE GELATINASE IMPLICATED IN THE PATHOGENESIS OF SJOGRENS-SYNDROME/

      Matrix biology
    65. KEMPPAINEN EAJ; HEDSTROM JI; PUOLAKKAINEN PA; HAAPIANINEN RK; STENMAN UH
      ADVANCES IN THE LABORATORY DIAGNOSTICS OF ACUTE-PANCREATITIS

      Annals of medicine
    66. VENESMAA P; STENMAN UH; FORSS M; LEMINEN A; LEHTOVIRTA P; VARTIAINEN J; PAAVONEN J
      PREOPERATIVE SERUM LEVEL OF TUMOR-ASSOCIATED TRYPSIN-INHIBITOR AND RESIDUAL TUMOR SIZE AS PROGNOSTIC INDICATORS IN STAGE-III EPITHELIAL OVARIAN-CANCER

      British journal of obstetrics and gynaecology
    67. Hedstrom, J; Svens, E; Kenkimaki, P; Kemppainen, E; Puolakkainen, P; Haapiainen, R; Stenman, UH
      Evaluation of a new urinary amylase test strip in the diagnosis of acute pancreatitis

      SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
    68. KEMPPAINEN E; HEDSTROM J; STENMAN UH
      DO TRYPSIN 2-ALPHA-1-ANTITRYPSIN COMPLEXES OCCUR NATURALLY IN THE CIRCULATION - REPLY

      Gut
    69. VARTIAINEN J; ALFTHAN H; LEHTOVIRTA P; STENMAN UH
      IDENTIFICATION OF CHORIOCARCINOMA BY THE HCG-BETA-TO-HCG PROPORTION IN PATIENTS WITH DELAYED DIAGNOSIS CAUSED BY CONTRACEPTIVE USE

      Contraception
    70. Zhang, WM; Finne, P; Leinonen, J; Vesalainen, S; Nordling, S; Rannikko, S; Stenman, UH
      Characterization and immunological determination of the complex between prostate-specific antigen and alpha(2)-macroglobulin

      CLINICAL CHEMISTRY
    71. BLOMQVIST C; VONBOGUSLAWSKI K; STENMAN UH; MAENPAA H; VONSMITTEN K; NORDLING S
      LONG-TERM PROGNOSTIC IMPACT OF IMMUNOHISTOCHEMICAL ESTROGEN-RECEPTOR DETERMINATIONS COMPARED WITH BIOCHEMICAL RECEPTOR DETERMINATION IN PRIMARY BREAST-CANCER

      Acta oncologica
    72. ZHANG WM; LEINONEN J; KALKKINEN N; STENMAN UH
      PROSTATE-SPECIFIC ANTIGEN FORMS A COMPLEX WITH AND CLEAVES ALPHA(1)-PROTEASE INHIBITOR IN-VITRO

      The Prostate
    73. VUENTO MH; STENMAN UH; PIRHONEN JP; MAKINEN JI; LAIPPALA PJ; SALMI TA
      SIGNIFICANCE OF A SINGLE CA-125 ASSAY COMBINED WITH ULTRASOUND IN THEEARLY DETECTION OF OVARIAN AND ENDOMETRIAL CANCER

      Gynecologic oncology
    74. HALME L; EDGREN J; TURPEINEN U; VONSMITTEN K; STENMAN UH
      URINARY-EXCRETION OF IOHEXOL AS A MARKER OF DISEASE-ACTIVITY IN PATIENTS WITH INFLAMMATORY BOWEL-DISEASE

      Scandinavian journal of gastroenterology
    75. KEMPPAINEN EA; HEDSTROM JI; PUOLAKKAINEN PA; SAINIO VS; HAAPIAINEN RK; PERHONIEMI V; OSMAN S; KIVILAAKSO EO; STENMAN UH
      RAPID MEASUREMENT OF URINARY TRYPSINOGEN-2 AS A SCREENING-TEST FOR ACUTE-PANCREATITIS

      The New England journal of medicine
    76. STENMAN UH
      PROSTATE-SPECIFIC ANTIGEN IN BENIGN PROSTATIC HYPERPLASIA - PURIFICATION AND CHARACTERIZATION - COMMENT

      The Journal of urology
    77. LINTULA S; STENMAN UH
      THE EXPRESSION OF PROSTATE-SPECIFIC MEMBRANE ANTIGEN IN PERIPHERAL-BLOOD LEUKOCYTES

      The Journal of urology
    78. TUOMINEN JA; EBELING P; STENMAN UH; HEIMAN ML; STEPHENS TW; KOIVISTO VA
      LEPTIN SYNTHESIS IS RESISTANT TO ACUTE EFFECTS OF INSULIN IN INSULIN-DEPENDENT DIABETES-MELLITUS PATIENTS

      The Journal of clinical endocrinology and metabolism
    79. SORSA T; SALO T; KOIVUNEN E; TYYNELA J; KONTTINEN YT; BERGMANN U; TUUTTILA A; NIEMI E; TERONEN O; HEIKKILA P; TSCHESCHE H; LEINONEN J; OSMAN S; STENMAN UH
      ACTIVATION OF TYPE-IV PROCOLLAGENASES BY HUMAN TUMOR-ASSOCIATED TRYPSIN-2

      The Journal of biological chemistry
    80. STENMAN J; LINTULA S; HOTAKAINEN K; VARTIAINEN J; LEHVASLAIHO H; STENMAN UH
      DETECTION OF SQUAMOUS-CELL CARCINOMA ANTIGEN-EXPRESSING TUMOR-CELLS IN BLOOD BY REVERSE TRANSCRIPTASE-POLYMERASE CHAIN-REACTION IN CANCER OF THE UTERINE CERVIX

      International journal of cancer
    81. KEMPPAINEN E; HEDSTROM J; PUOLAKKAINEN P; HALTTUNEN J; SAINIO V; HAAPIAINEN R; KIVILAAKSO E; STENMAN UH
      INCREASED SERUM TRYPSINOGEN-2 AND TRYPSIN-2-ALPHA(1) ANTITRYPSIN COMPLEX VALUES IDENTIFY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY INDUCED PANCREATITIS WITH HIGH-ACCURACY

      Gut
    82. KEMPPAINEN E; HEDSTROM J; PUOLAKKAINEN P; SAINIO V; HAAPIAINEN R; PERHONIEMI V; KIVILAAKSO E; STENMAN UH
      SIMPLE URINARY TRYPSINOGEN-2 TEST STRIP FOR SCREENING ACUTE-PANCREATITIS

      Gastroenterology
    83. PUOLAKKAINEN P; KEMPPAINEN E; HEDSTROM J; HALTTUNEN J; SAINIO V; HAAPIAINEN R; KIVILAAKSO E; STENMAN UH
      INCREASED SERUM TRYPSINOGEN-2 AND TRYPSIN-2-ALPHA(1)-ANTITRYPSIN COMPLEX VALUES IDENTIFY ERCP-INDUCED PANCREATITIS WITH HIGH-ACCURACY

      Gastroenterology
    84. KEMPPAINEN E; HEDSTROM J; PUOLAKKAINEN P; HALTTUNEN J; SAINIO V; HAAPIAINEN R; STENMAN UH
      URINARY TRYPSINOGEN-2 TEST STRIP IN DETECTING ERCP-INDUCED PANCREATITIS

      Endoscopy
    85. TURPEINEN U; MARKKANEN H; VALIMAKI M; STENMAN UH
      DETERMINATION OF URINARY FREE CORTISOL BY HPLC

      Clinical chemistry
    86. STENMAN UH; UNKILAKALLIO L; KORHONEN J; ALFTHAN H
      IMMUNOPROCEDURES FOR DETECTING HUMAN CHORIONIC-GONADOTROPIN - CLINICAL ASPECTS AND DOPING CONTROL

      Clinical chemistry
    87. KORHONEN J; ALFTHAN H; YLOSTALO P; VELDHUIS J; STENMAN UH
      DISAPPEARANCE OF HUMAN CHORIONIC-GONADOTROPIN AND ITS ALPHA-SUBUNITS AND BETA-SUBUNITS AFTER TERM PREGNANCY

      Clinical chemistry
    88. STENMAN UH
      PROSTATE-SPECIFIC ANTIGEN, CLINICAL USE AND STAGING - AN OVERVIEW

      British Journal of Urology
    89. SALONEN R; TURPEINEN U; KURKI L; LAPPALAINEN M; AMMALA P; HIILESMAA V; TERAMO K; VONKOSKULL H; GAHMBERG N; STENMAN UH
      MATERNAL SERUM SCREENING FOR DOWNS-SYNDROME ON POPULATION BASIS

      Acta obstetricia et gynecologica Scandinavica
    90. LEINONEN J; STENMAN UH
      SIGNIFICANCE OF FREE AND BOUND PROSTATE-SPECIFIC ANTIGEN

      Endocrine-related cancer
    91. HEDSTROM J; SAINIO V; KEMPPAINEN E; HAAPIAINEN R; KIVILAAKSO E; SCHRODER T; LEINONEN J; STENMAN UH
      SERUM COMPLEX OF TRYPSIN 2 AND ALPHA(1) ANTITRYPSIN AS DIAGNOSTIC ANDPROGNOSTIC MARKER OF ACUTE-PANCREATITIS - CLINICAL-STUDY IN CONSECUTIVE PATIENTS

      BMJ. British medical journal
    92. STENMAN UH; LEINONEN J; ZHANG WM
      PROBLEMS IN THE DETERMINATION OF PROSTATE-SPECIFIC ANTIGEN

      European journal of clinical chemistry and clinical biochemistry
    93. ALFTHAN H; STENMAN UH
      PATHOPHYSIOLOGICAL IMPORTANCE OF VARIOUS MOLECULAR-FORMS OF HUMAN CHORIOGONADOTROPIN

      Molecular and cellular endocrinology
    94. KORHONEN J; TIITINEN A; ALFTHAN H; YLOSTALO P; STENMAN UH
      ECTOPIC PREGNANCY AFTER IN-VITRO FERTILIZATION IS CHARACTERIZED BY DELAYED IMPLANTATION BUT A NORMAL INCREASE OF SERUM HUMAN CHORIONIC-GONADOTROPIN AND ITS SUBUNITS

      Human reproduction
    95. HEDSTROM J; KORVUO A; KENKIMAKI P; TIKANOJA S; HAAPIAINEN R; KIVILAAKSO E; STENMAN UH
      URINARY TRYPSINOGEN-2 TEST STRIP FOR ACUTE-PANCREATITIS

      Lancet
    96. PIIRONEN T; PETTERSSON K; SUONPAA M; STENMAN UH; OESTERLING JE; LOVGREN T; LILJA H
      IN-VITRO STABILITY OF FREE PROSTATE-SPECIFIC ANTIGEN (PSA) AND PROSTATE-SPECIFIC ANTIGEN (PSA) COMPLEXED TO ALPHA(1)-ANTICHYMOTRYPSIN IN BLOOD-SAMPLES

      Urology
    97. BJORK T; PIIRONEN T; PETTERSSON K; LOVGREN T; STENMAN UH; OESTERLING JE; ABRAHAMSSON PA; LILJA H
      COMPARISON OF ANALYSIS OF THE DIFFERENT PROSTATE-SPECIFIC ANTIGEN FORMS IN SERUM FOR DETECTION OF CLINICALLY LOCALIZED PROSTATE-CANCER

      Urology
    98. SAINIO V; PUOLAKKAINEN P; KEMPPAINEN E; HEDSTROM J; HAAPIAINEN R; KIVISAARI L; STENMAN UH; SCHRODER T; KIVILAAKSO E
      SERUM TRYPSINOGEN-2 IN THE PREDICTION OF OUTCOME IN ACUTE NECROTIZINGPANCREATITIS

      Scandinavian journal of gastroenterology
    99. KARI MA; RAIVIO KO; STENMAN UH; VOUTILAINEN R
      SERUM CORTISOL, DEHYDROEPIANDROSTERONE-SULFATE, AND STEROID-BINDING GLOBULINS IN PRETERM NEONATES - EFFECT OF GESTATIONAL-AGE AND DEXAMETHASONE THERAPY

      Pediatric research
    100. KORHONEN J; STENMAN UH; YLOSTALO P
      LOW-DOSE ORAL METHOTREXATE WITH EXPECTANT MANAGEMENT OF ECTOPIC PREGNANCY

      Obstetrics and gynecology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 15/01/21 alle ore 21:53:31